DOVER, N.J., Aug. 5 /PRNewswire/ -- Germgard Lighting LLC, a New Jersey-based medical technology company, has demonstrated a breakthrough advancement of its gas-based, room-temperature surgical instrument sterilization system.
An independent testing laboratory is consistently achieving 100% kill of Geobacillus stearothermophilus, the standard spore used for testing surgical instrument sterilizers. The tests employ a single, three-minute cycle, including preparation. The inactivation remains at 100% after 7 days of controlled observation, hence is fully compatible with a single cycle. Germgard continues to optimize the process, confidently expecting no more than an unprecedented double cycle of six minutes total time for lumen devices such as endoscopes and for Prion inactivation on neurological tools.
Reduced cycle time and room-temperature sterilization are important since they reduce instrument damage, shorten inventory turnaround time and reduce the number of necessary equipment operators -- critical considerations for efficiency and ongoing cost savings.
The total cycle time for the process is so much shorter than for steam sterilization or any room-temperature, gas-based sterilizer process that Germgard expects that current technologies will become obsolete and be supplanted by Germgard's system.
The proprietary gas medium used for sterilization is unlike any in current use and is safe, easy-to-use and short-lived, disappearing before the exposure pouch is opened. The system can be fully automated, requiring no high-temperature presoak, no instrument pre-wrapping by technicians, no cool-down period and no time lost for drying or special handling. It is expected to be suitable for all surgical instruments.
According to Germgard's CEO, Dr. Eugene I. Gordon, "Commercialization and implementation of our solution will positively impact large he
|SOURCE Germgard Lighting LLC|
Copyright©2009 PR Newswire.
All rights reserved